Cognition Therapeutics, Inc.
NASDAQ:CGTX
0.3724 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 25.009 | 29.922 | 41.562 | 54.721 | 5.189 | 2.89 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 25.009 | 29.922 | 41.562 | 54.721 | 5.189 | 2.89 |
| Net Receivables
| 2.686 | 1.281 | 3.672 | 2.266 | 1.152 | 4.124 |
| Inventory
| 0 | 0 | 0 | 1.994 | 0.544 | 0.117 |
| Other Current Assets
| 1.86 | 3.019 | 2.413 | 2.005 | 0.567 | 0.146 |
| Total Current Assets
| 29.555 | 34.222 | 47.647 | 58.992 | 6.908 | 7.16 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.679 | 0.941 | 1.046 | 0.145 | 0.211 | 0.299 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 1.732 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0.679 | 0.941 | 2.778 | 0.145 | 0.211 | 0.299 |
| Total Assets
| 30.234 | 35.163 | 50.425 | 59.137 | 7.119 | 7.459 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.984 | 3.695 | 3.216 | 4.168 | 2.003 | 2.357 |
| Short Term Debt
| 0.193 | 0.718 | 0.298 | 0 | 0 | 0.004 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 1.066 | 1.701 | 1.702 | 0.753 | 0 | 1.321 |
| Other Current Liabilities
| 7.899 | 4.055 | 2.579 | 3.696 | 1.247 | 1.322 |
| Total Current Liabilities
| 11.142 | 10.169 | 7.795 | 7.864 | 3.25 | 3.683 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.342 | 0.52 | 1.39 | 0 | 12.852 | 6.897 |
| Deferred Revenue Non-Current
| 0 | 0 | 1.686 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -0.695 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -0.695 | 0 | 59.201 | 55.301 |
| Total Non-Current Liabilities
| 0.342 | 0.52 | 2.381 | 0 | 72.053 | 62.198 |
| Total Liabilities
| 11.484 | 10.689 | 10.176 | 7.864 | 75.303 | 65.881 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 59.137 | 0.055 | 0.053 |
| Common Stock
| 0.06 | 0.032 | 0.029 | 0.022 | 0.001 | 0.001 |
| Retained Earnings
| -175.16 | -141.189 | -115.401 | -94.004 | -68.22 | -58.239 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.195 | -0.199 | -0.198 | -0.187 | -0.185 |
| Other Total Stockholders Equity
| 193.85 | 165.826 | 155.82 | 145.453 | 0.222 | 0.001 |
| Total Shareholders Equity
| 18.75 | 24.474 | 40.249 | 51.273 | -68.184 | -58.422 |
| Total Equity
| 18.75 | 24.474 | 40.249 | 51.273 | -68.184 | -58.422 |
| Total Liabilities & Shareholders Equity
| 30.234 | 35.163 | 50.425 | 59.137 | 7.119 | 7.459 |